253 related articles for article (PubMed ID: 36345477)
1. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract][Full Text] [Related]
2. Integrating Network Pharmacology and In Vitro Experiments for Assessing the Anti-Tumor Effects of Phyllanthus Urinaria L Anti-neoplastic Decoction in Hepatocellular Carcinoma.
Wei C; Wu Z; Yang X; Jiang X; Wang L; He J; Tong G
Altern Ther Health Med; 2024 May; ():. PubMed ID: 38758152
[TBL] [Abstract][Full Text] [Related]
3. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology.
Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415
[TBL] [Abstract][Full Text] [Related]
4. A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma.
Zhou X; Tan F; Zhang S; Wang A; Zhang T
Curr Pharm Des; 2024; 30(5):377-405. PubMed ID: 38310567
[TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
[TBL] [Abstract][Full Text] [Related]
6. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments.
Li S; Liu W; Wang TT; Chen TQ; Guo JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14428. PubMed ID: 38230768
[TBL] [Abstract][Full Text] [Related]
7. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
Guo BJ; Ruan Y; Wang YJ; Xiao CL; Zhong ZP; Cheng BB; Du J; Li B; Gu W; Yin ZF
J Integr Med; 2023 Sep; 21(5):474-486. PubMed ID: 37453868
[TBL] [Abstract][Full Text] [Related]
8. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
[TBL] [Abstract][Full Text] [Related]
9. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro.
Luo J; Chen QX; Li P; Yu H; Yu L; Lu JL; Yin HZ; Huang BJ; Zhang SJ
J Ethnopharmacol; 2024 Jan; 318(Pt A):116886. PubMed ID: 37429502
[TBL] [Abstract][Full Text] [Related]
10. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
11. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
[TBL] [Abstract][Full Text] [Related]
13. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract][Full Text] [Related]
14. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology.
Zhang C; Xiang H; Wang J; Shao G; Ding P; Gao Y; Xu H; Ji G; Wu T
J Ethnopharmacol; 2023 Dec; 317():116676. PubMed ID: 37279814
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway.
Shi H; Deng L; Zhou Y; Yu H; Huang X; Chen M; Lei Y; Dong J
J Ethnopharmacol; 2023 Oct; 315():116691. PubMed ID: 37247682
[TBL] [Abstract][Full Text] [Related]
16. Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma.
Wang H; Chen W; Cui Y; Gong H; Tang A
Aging (Albany NY); 2023 Aug; 15(15):7831-7843. PubMed ID: 37556351
[TBL] [Abstract][Full Text] [Related]
17. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
[TBL] [Abstract][Full Text] [Related]
18. Exploring the mechanisms underlying the therapeutic effect of the
Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
[TBL] [Abstract][Full Text] [Related]
19. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
Xia J; Rong L; Sawakami T; Inagaki Y; Song P; Hasegawa K; Sakamoto Y; Tang W
Biomed Pharmacother; 2018 Mar; 99():921-930. PubMed ID: 29710492
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
